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The first studies on thiourea in this department were undertaken for
reasons quite apart from the purposes for which it is now used. It had been
reported that this compound distributed itself uniformly throughout the
fluids of the body, that it was excreted like urea and could be recovered in
the urine, completely, unchanged.31 These characteristics, if they could be
verified, would make thiourea an ideal means of measuring the total volume
of water in the body. When the subject was investigated by Purple and
Lavietes," it was discovered that large doses of thiourea, 6 to 10 gm.,
induced severe nausea and vomiting with malaise, but no other discernible
symptoms. Measurements of its volume of distribution and excretion
yielded values that lent plausibility to the idea that it diffused freely through
all the water and escaped destruction. Subsequently it was found that in
somewhat smaller doses it produced offensive halitosis.
Because of its untoward effects it was evident that the compound must be
given in smaller doses if it was to be used for physiological studies. This
required the development of a more sensitive analytical technique. A pro-
cedure was, therefore, devised which permitted measurements of the desired
accuracy when doses of about one-tenth the former magnitude were used.'
When such doses, 0.5 gm., were injected into dogs, it proved impossible to
recover the whole of the injected dose in the urine.' A small fraction
appeared to be disposed of in some manner. This had not been detected in
the earlier studies because this fraction was so small in proportion to the
large doses that had been given. With this quantity of thiourea the dogs,
with the exception of one which invariably vomited, exhibited no untoward
signs or symptoms, and postmortem examinations of animals who died
from other causes incident to the experiments revealed no lesions that could
be attributed to any untoward actions of the drug. Obviously thiourea was
unsuited to the purpose for which it had been intended-measurement of
the total fluid of the body. It could be inferred from its incomplete recovery
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and the fact that large doses had a toxic action that the compound was not
physiologically inert nor altogether unchanged in the body. Nevertheless,
it seemed to have been established that single doses of moderate size had
no deleterious effects. To make assurance doubly sure, some time later a
number of patients were given intravenously test doses of 0.4 to 1.0 gm.
The largest dose occasionally caused mild nausea or vomiting.
The latter part of this work coincided with the appearance of reports that
thiourea and other drugs containing sulfur in a similar linkage produced in
animals goiters with hypothyroidism. One of these, thiouracil, had been
employed for the treatment of hyperthyroidism with reported success.
Thiourea had been rejected for two principal reasons. In rats, large doses
of the compound had been found to precipitate fatal pulmonary edema with
pleural effusions. In addition, experiments with certain species of animals
had indicated that it had less goitrogenic activity than thiouracil did.2"4 5 "
In spite of these adverse decisions it was decided to use thiourea for a study
of the medical treatment of hyperthyroidism. Since an accurate method for
its measurement in body fluids was available, its metabolism could be
studied. The experiments cited above had proved that doses of the size
contemplated for therapeutic use provoked neither in man nor dogs the
disorders that larger doses had produced in rats. The incidence of these
acute lesions in rats had proved to be peculiar and capricious, susceptibility
varying with age, diet, and variety.1'"""17' 1 "' In most other species tested
the compound had proved innocent. Astwood' has stated that thiourea is the
least toxic of a large number of effective drugs which he tested. In dogs,
doses which had no detectable evil effects depressed thyroid activity.1' It was
soon demonstrated that it was equally effective in low dosage as an anti-
thyroid agent in patients with hyperthyroidism.' It was conceived that
thiourea, being chemically the simplest member of its group, might display
the action of the thio-linkage with a minimum of side effects. Reports of
agranulocytosis and its attendant disorders, from thiouracil, had already
begun to appear. The presence of a ring in thiouracil, it was argued, might
well provoke agranulocytosis, whereas thiourea, without a ring, might not.
Certain other decisions were reached at the same time: (i) that iodine
in therapeutic doses should be given with thiourea; (ii) that the policy of
giving no barbiturates or other sedative drugs, with the occasional exception
of soporific doses of chloral hydrate, should be followed more rigorously
than before. Iodine was given to allay any possible goitrogenic action of
thiourea and to accelerate its antithyroid effect. It had been claimed by
numerous observers8'9X19 21. 25, 3 42. that preliminary treatment with iodine
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delayed or even inhibited the action of thiouracil. The evidence to this effect
was not altogether convincing. On theoretical grounds, it seemed illogical
that they should be antagonistic, since in hyperthyroidism both drugs,
though differing in their mode of action, had an inhibitory effect. The use of
barbiturates in the treatment of hyperthyroidism has been generally dis-
couraged because it is felt that their depressing effects are not beneficial to
patients with this condition. They were prohibited in the series treated
with thiourea lest they confuse the issue. If they were given, it would be
impossible to distinguish with certainty whether rashes, agranulocytosis,
and other toxic manifestations were caused by thiourea or barbiturates.
This point has been too often overlooked. Many reports of intoxication
from thio-drugs can not be properly evaluated either because barbiturates
were given or because it was impossible to ascertain from the reports
whether or not they were given. As far as possible in this series other drugs
which could cause similar confusion were avoided.
As means of checking the effects of therapy, chief reliance was placed
upon periodical measurement of the precipitable iodine of the serum, SPL.'
Basal metabolism was also determined in most cases and, in a certain
number, serum lipids as well. The present communication deals with possi-
ble toxic effects of thiourea.
In one respect the course which was elected has been justified. Evidence
has been adduced that the actions of iodine and thiourea are not antago-
nistic.'"' By the initial use of iodine, hyperthyroidism may be partially
alleviated before the effect of the slower-acting thiourea is attained. Iodine
also appears to augment the effect of thiourea. Continuous use of the two
drugs in combination, therefore, permits control of hyperthyroidism with
smaller doses of thiourea than would otherwise be necessary. This must
diminish the danger of any toxic action that the thio-drug might exert. The
experience of Rawson and associatesM agrees with our own in these respects.
As far as the antigoitrogenic action of the iodine is concerned, no opinion
can be given. In no case was there any evidence that thiourea given with
iodine had a goitrogenic action. In the few patients who came to operation
after this therapy, the thyroid glands did not appear to be more vascular
or hyperplastic than glands from subjects who had been prepared for opera-
tion by iodine alone. This evidence must be discounted, however. Although
it has been established that thio-drugs have a goitrogenic action on euthyroid
animals, there is no indisputable evidence that they have a similar effect on
the glands of patients with hyperthyroidism. Many have reported diminu-
tion in the size of the hyperthyroid gland under the influence of thio-drugs,
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though sometimes after a preliminary swelling. This latter phenomenon is,
however, occasionally observed when iodine is used. Lahey and his associ-
ates' have emphasized the great vascularity of glands after treatment with
thiouracil alone. Although they believe that iodine retards the action of
thiouracil when the two are given together initially, they are convinced that
it reduces the vascularity of the gland if given for two or three weeks before
operation after the effect of thiouracil has been obtained. Enlargement of
the thyroid gland is likely to occur if combined iodine and thio-drug therapy
is pushed to such a point that it produces myxedema. An example of this
is cited below.
Evaluation of the relative antithyroidal activity of the various thio-drugs
has not been entirely satisfactory. The majority of pharmacological studies
have employed as their sole criterion the degree of hyperplasia of the
thyroid gland of rats. On the basis of such assays Astwood,1 who has made
the most intensive investigation, estimates that 0.6 mg. of thiouracil is as
effective as 2.1 mg. of thiourea, while 6-propylthiouracil is still more potent.
On a molecular basis this would mean that thiouracil is six times as effective
as thiourea. In most of these assays thiourea has been treated rather
cavalierly or neglected. The few who have employed the compound thera-
peutically seem to have taken it for granted that these assays apply to man
and have usually used 1 gm. or more per day in a rather arbitrary manner,
to the discredit of the compound.2'
"" "' For example, Morgans' used 3 gm.
per day, in contrast to 0.6 to 1.0 gm. of thiouracil and 0.6 gm. of methyl
thiouracil and aminothiazole. Ritchie and Geddes' used from 2 to 5 gm. per
day. Such large doses invariably produced objectionable halitosis and other
untoward symptoms and signs. In a preliminary evaluation of the drug,
Winkler, Man, and Danowski47 showed that doses as small as 70 mg. daily
produced or maintained a remission in hyperthyroidism with considerable
regularity, and that as little as 25 to 50 mg. daily sometimes maintained
such a remission. The drug was used by them in conjunction with iodine,
which augments its action. Further experience has proved that the required
dose varies from these small amounts to about 210 mg. daily. A few patients
have been found who did not respond completely to this large dose-or
rather, who at times could not be controlled with such a dose. This will be
the subject of a separate report. The point is brought up now to emphasize
that, gram for gram, thiourea appears from our experience to be more
effective than other thio-drugs that have been widely used. If, however, the
action of these drugs depends upon the thio-linkage, they should be rated
not according to actual weight, but according to the quantity of sulfur they
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contain. The molecular ratio, thiourea: propylthiouracil = 76: 170=
0.45. On this basis thiourea should be roughly twice as effective, gram for
gram, as propylthiouracil. In estimating both its effectiveness and its
toxicity, this must be taken into account. In evaluating toxicity this is
particularly important, because only by making the comparison on this
basis will it be possible to distinguish whether an unfavorable reaction
should be ascribed to the thio group, to the whole class of drugs, or to a
particular member of this class.
Toxic or untoward reactions
The chief untoward effects that have thus far been reported from the
therapeutic use of thio-drugs are: (i) febrile reactions, (ii) skin rashes of
various kinds, (iii) leucopenia and agranulocytosis, (iv) muscle pains,
arthralgia, and arthritis, (v) miscellaneous disturbances of the gastro-
intestinal tract, genito-urinary tract, liver, etc. These last have been so
occasional that it is quite uncertain whether they can always be related
directly to the drugs to which they have been attributed. Some of them may
be referable only to particular drugs. Our attention will be confined chiefly
to the first 4 types of reactions.
In one respect thiourea appears to be distinguished from all of the other
drugs of its class that have as yet been employed for therapeutic purposes.
Approximately 300 cases have now received the compound for the treat-
ment of hyperthyroidism in this clinic for periods up to almost 4 years
without a single instance of agranulocytosis or significant leucopenia. Blood
counts were made with great frequency on all cases for a long period and
are still made at sufficiently frequent intervals to assure us that reductions
of leucocytes have not escaped our attention. Two cases have been men-
tioned by Ritchie and Geddes. One, from their own series, developed
agranulocytosis after 3 months' treatment with extremely large doses of
thiourea. The other case they cite by courtesy of another physician without
details. Leucopenia and agranulocytosis have occurred with varying fre-
quency after therapeutic doses of all the members of the thiouracil group:
thiouracil,2'28"' U,41,"thiobarbital,6'10 6-propylthiouracil,' 5-methylthioura-
cil7'2'0 and others.' The cases of Ritchie and Geddes' cast doubt upon the
presumption that the absence of a ring form would preclude this complica-
tion. Dosage may play its part. Thiourea does appear to have less tendency
than the thiouracils to produce leucopenia and agranulocytosis.
Altogether 35 patients at one time or another in the course of treatment
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with thio-drugs, chiefly thiourea,* developed complications of some kind.
These patients and their records have been carefully scrutinized to ascertain
whether these disorders could be attributed to toxic effects of the thio-drugs.
All those in which there was reasonable suspicion are discussed in this
report, even though the evidence against thiourea is quite tenuous in certain
cases. In 17 of the 35 cases thiourea could be clearly exonerated; in 6 it was
as clearly convicted. The remaining 12, of whom 5 died, will be the chief
subjects of discussion in this paper.
One patient developed urticaria which seemed to be directly referable to
thiourea. A woman of 45 with Graves' disease of 2 months' duration had
a basal metabolism of +32 per cent and a serum precipitable iodine of
11.4 y per cent. On 15 drops of Lugol's solution and 15 mg. of thiourea
daily, basal metabolism and serum iodine became normal and symptoms
disappeared in 6 months. After 10 months, medications were stopped. Four
months later they had to be resumed because of a relapse, and after another
2 months the thiourea was increased to 25 mg. daily. After she had taken
the drug daily, with the exception of the intermission mentioned above, for
22 months, she developed urticaria which ceased within 24 hours after she
stopped the thiourea. On 2 subsequent occasions, at intervals of about 5
days, small single doses of thiourea precipitated attacks of urticaria which
each time lasted only 24 hours. Propylthiouracil in the same dosage pro-
voked no such reaction, but did not control the hyperthyroidism completely,
as evidenced by a continuous slight elevation of the serum iodine. The urti-
carial reaction in this case appeared to be specific for thiourea, although
this can not be asserted with certainty since the dose of propylthiouracil
with which the thiourea was replaced contained only half as much sulfur.
Furthermore, this reaction came on, as similar reactions to insulin some-
times do, while the subject was receiving continuously doses of the drug
that should have desensitized her. It is possible that, had thiourea been
continued, the urticarial reaction would have ceased as the urticarial re-
actions to insulin usually do. Since a substitute was available, this rather
trying process was not tested.
No other urticarial rashes, no exfoliative nor other types of generalized
dermatitis have occurred. Certain peculiar skin disorders will be mentioned
below in another connection.
In two instances the drug was discontinued because it produced nausea.
The first, A22701, a woman of 53, in 1943 was given 1 gm. of thiourea
* Thiourea was most frequently implicated because at the time of this study it was
almost exclusively employed.
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daily. This caused severe nausea and was, therefore, discontinued within
a week. The nausea in this case was due only to excessive doses of the
drug; it can be ascribed to inexperience and discounted. The second patient,
B74809, born in 1883 (a sister of B73276, who is mentioned below as hav-
ing had an early febrile reaction), had a thyroidectomy for hyperthyroidism
in 1930. She came to the clinic December 24, 1945, two weeks after an
anginal attack, with symptoms and signs of hyperthyroidism and a blood
pressure 190/100. She had been taking 10 drops of Lugol's solution daily
since her previous operation and had been digitalized at the time of her
anginal attack. On December 17 the basal metabolism was +17 per cent,
SPI 12.0 y per cent. She was given 15 drops of Lugol's solution and 75 mg.
of thiourea, which was increased to 210 mg. daily 3 days later. Because
of nausea and vomiting this was reduced to 25 mg. on January 18, although
SPI was 11.3 y per cent. Subsequently, because she failed to improve, the
dose was increased successively to 50, 75, and 100 mg. Nausea again com-
pelled reduction of the dose to 75 mg. On this the basal metabolism and
pulse were controlled, but SPI remained consistently elevated and symp-
toms did not seem to be allayed. On August 3 the dose was again raised to
100 mg., and again nausea appeared after a few days. For this reason on
August 21, 100 mg. of propylthiouracil daily was substituted. This did not
provoke nausea. In this case the nausea seemed to be directly referable
to intolerance for thiourea and related to the dose of the drug. It was
associated with no other symptoms and no objective signs. It may have
represented merely an aversion to the drug.
Three patients have had simple febrile reactions. These appeared on the
7th, 9th, and 13th days of medication with thiourea, respectively. The first
two patients had received 210 mg., the third 70 mg., daily. In every case the
temperature fell rapidly after the drug was discontinued and rose sharply
when it was given again. The only associated symptom was general malaise.
In every instance the drug was discontinued. One of the patients was sub-
jected to thyroidectomy. Febrile reactions of this type have been described
after all the thio-drugs: thiourea," thiouracil23,24,"26,32,41,4 thiobarbital,
5-methylthiouracil,7' '5' '8 propylthiouracil,'5 and others.'5 They usually ap-
pear, as these did, within 7 to 14 days after initiation of therapy. Presum-
ably, therefore, they are manifestations of sensitization to these compounds.
They may be induced by small doses as they were in the last of our cases;
but they are more frequently provoked by large doses. Morgans,'5 for
example, reports 6 febrile reactions of this type in 7 cases who received
3 gm. of thiourea daily. This suggests that their frequency might be reduced
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to a minimum by the use of small doses for the first 2 or 3 weeks of treat-
ment. Although early febrile reactions have been induced by all the thio-
derivatives and may, therefore, be regarded as one of the generic responses
to these drugs, they are not altogether non-specific. A large proportion of
patients do not respond with fever when another compound is substituted,
though this is not always the case.'1 ' l S This was not tested on any of
the patients in this series. Nor was the drug continued in spite of the fever
as it has been by some clinicians who claim that this is a self-terminative
type of reaction. It has not seemed justifiable to us to continue a therapeutic
procedure in the face of such untoward reactions when there are alternate
courses to pursue. Desensitization by small doses has not been attempted.
In most reports no distinction has been drawn between these early febrile
reactions and later febrile disorders. In our experience the patterns of the
two differ. Arthritis, myalgia, and other disorders of the musculo-skeletal
system have been reported as occurring with varying frequency in the
course of treatment with all of the thio-drugs.?'""'' "'" Nevertheless, no
accurate descriptions of these disorders nor their relation to therapy can be
found in the literature. To us they have seemed to merit particular attention.
Polyarthritis, even if it appears to be rapidly self-terminative, is not a con-
dition that can be lightly regarded in view of our present concepts of
rheumatic and rheumatoid affections. The association of myalgic pains,
rashes, and fever, quite casually mentioned in many reports, should cause
some anxiety. In this spirit we have followed with great care and no little
bewilderment the course of all febrile complications occurring during
thiourea therapy. Every effort has been made to ascertain whether such
complications could be related to the therapy, frequently with baffling
results. These studies are the chief theme of this report. Altogether, 12
patients had late febrile disorders, usually accompanied by pains in the
muscles or joints, sometimes by obvious arthritis, and by peculiar multiform
skin lesions. Five of these patients died and autopsies were obtained on all.
Protocols of all are presented, because only by such a comparison can the
relation of their disorders to the drug be properly evaluated.
B45335 (JN), female, born in 1875, according to her record had partial thyroidectomy
in 1895 (the date must be erroneous) for hyperthyroidism of two years' duration, with
only partial relief of sym.ptoms. Emotional and exertional palpitation and excessive
sweating persisted and the goiter enlarged. In 1930 she was institutionalized for a
nervous breakdown. In 1944 she developed conjunctivitis and increased intraocular
tension. In 1945, with buzzing in her head, hypertension was discovered. When seen in
the dispensary, September 28, 1945, she was sweating, nervous and tremulous, with
pulse 132, blood pressure 215/120, moderate exophthalmos, bilateral lenticular opacities,
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a low midline goiter, and a slightly enlarged heart with an aortic systolic murmur.
Six weeks later her basal metabolism was +24 per cent, SPI 8.3 'y per cent.
NovDcc Jan Ma Apr May Jul
1945 9 5 3 8 5 24 9
Luqol, drops j jj51 |
Thioura,mq 210 I 7IIII 0 I 7
8 45335
CHART 1. The two upper horizontal lines define the limits of variation of normal
SPI, the lowest horizontal line the upper limit of normal rectal temperature. The time
scale is contracted during the period to the left of the double vertical line, while the
subject was not in the hospital.
Her course is illustrated in Chart 1. Thiourea (210 mg. daily) was continued (with
the exception of 2 weeks at the end of January, 1946) until her admission to the
hospital on August 22. Early in March, 15 drops of Lugol's solution daily were added.
The serum iodine responded promptly, but basal metabolism and pulse remained
elevated. May 24 nocturnal dyspnea and inability to lift the right arm were reported.
Though there was no edema, hepatic enlargement, nor pulmonary congestion, digitalis
was given. July 9 SPI had risen and basal metabolism reached a new high. Iodine had
been discontinued for a short period before this, but its resumption did not check the
rises. August 19, after an upper respiratory infection, she developed arthritic pains.
August 22 she was admitted to the hospital with temperature 102.4°, swelling, tender-
ness and pain in both knees and the right ankle, and pain on motion of several other
joints. Heart and liver were both enlarged, but lungs were clear and there was no
edema. The dose of thiourea was at once reduced and for Lugol's solution there was
substituted KI, which was discontinued 5 days later. August 24 the submaxillary
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glands became swollen an-d tender. August 25 she had pleuritic pains. Her temperature
subsided after about a week, the pulse rate decreasing at the same time; but the joint
pains persisted with diminishing severity until October 10. X-rays on September 12 and
at intervals thereafter revealed pneumonitis of both lower lobes and a pleural effusion
on the right, but no fluid could be obtained on repeated attempts at thoracentesis. On
one occasion a transient papulovesicular eruption appeared on her elbow. Because SPI
had risen to 13.9 -y per cent on September 18, thiourea was increased to 150 mg. daily.
She continued afebrile, her symptoms disappeared, and the SPI fell on this regime.
The blood count remained normal throughout the course of her illness. In addition to
the disorders already described, x-ray revealed hypertrophic osteoarthritis, generalized
osteoporosis and posterior dislocation of the 5th cervical vertebra on the 4th. On
October 10 a fracture of the 8th rib in the mid-axillary line was also discovered. The
patient did not return after her discharge from the hospital.
There are several puzzling features in this case, the first being the
discrepancy between pulse and basal metabolism on the one hand and SPI
on the other during the early part of her course, when her weight was
declining steadily. If the rise of SPI in July had been referable to with-
drawal of iodine, it should have fallen again instead of rising when iodine
was resumed. The increases of both SPI and basal metabolism at this time
may have been connected with the complicating condition that later mani-
fested itself as arthritis. The subsidence of the arthritis when the dose of
thiourea was reduced may have been only a coincidence, since it continued
to subside when the dose was again raised to 140 mg. per day. What might
have happened if it had been raised further to the original 210 mg., it is
impossible to say. Since the SPI appeared to be falling and symptoms were
diminishing on 140 mg., the effect of a larger dose was not tested. On
the whole the patient could not be convicted unequivocally of thiourea
intoxication.
B73533 (ES), female, born in 1876, had typhoid fever in 1890, broke her hip in 1941,
and in the same year had a cholecystectomy and a hernioplasty. In 1944 she had a
hemorrhoidectomy. In 1942, exertional dyspnea, palpitation, and edema began. From
about 1931 her tongue had been sore. At the end of 1944 anorexia and frequent head-
aches set in. Between 1942 and 1945 her weight fell from 226 to 135 pounds. In March
or April, 1945, she began to have difficulty swallowing solid food. In June, diagnoses
of esophageal diverticulum and hyperthyroidism were made. She was admitted to the
New Haven Hospital on October 19, extremely wasted, with an enlarged thyroid,
pulse 82, blood pressure 164/74, enlarged fibrillating heart, slightly enlarged liver,
edema of the legs, a slight cystocele, and a red tongue with smooth edges. Her chief
complaints were dysuria and diarrhea. The stools were reported as distinctly fatty and
x-rays revealed osteoporosis. A low-grade temperature, attributed to urinary tract
infection, was treated with penicillin. X-ray also revealed a pulsion diverticulum of the
esophagus. Early in November the basal metabolism was found to be +29 per cent.
SPI 21.4 and 18.1 -y per cent. Her course is illustrated in Chart 2.
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CHART 2. The two upper horizontal lines define the limits of variation of normal
SPI, the lowest horizontal line the upper limit of normal rectal temperature. The first
double vertical line represents an interval when the patient was not in the hospital and
not observed. Between the second and third double vertical lines, while the subject
was an outpatient, the time scale is contracted.
On November 12, just after her temperature had become normal, she was started
on 210 mg. of thiourea and 15 drops of Lugol's solution daily. Three days later the
temperature rose again. Because the urine was found to be infected she was given
sulfadiazine. The temperature ceased after about 10 days, to recur a little later, when
penicillin was again given. December 9, when the basal metabolism had fallen to +8 per
cent and SPI to 9.2 -y per cent, both thiourea and Lugol's were stopped.
She was discharged from the hospital on December 13. Just before this dysuria and
frequency occurred; by the end of the month, they had become so severe that she was
readmitted December 31. She was given 420 mg. of thiourea that day and thereafter
210 mg. with 15 drops of Lugol's solution daily. She also received sulfadiazine for
a few days. By February 4 SPI had fallen to 6.7 y per cent; but irregular bouts of
fever continued and the urinary infection persisted. February 12 a colpoperineoplasty
was performed because the cystocele was believed to be responsible for the persistence
of the cystitis. The thiourea meanwhile had been reduced to 70 mg. daily. She remained
in the hospital until March 10, afebrile and free from symptoms.
For some time after discharge she remained relatively free from symptoms, though
SPI was elevated. October 29, 1947, a brawny, erythematous patch appeared on her
right thigh and she complained of pulling and soreness in the right upper quadrant of
her abdomen. The liver edge was down 2 to 3 fingerbreadths. On the earlier admissions
some evidences of impaired liver function had been noted. April 23, 1948, she had
recurrent chills and sweats and occasional right upper quadrant pain which, she said,
resembled an attack she had had 30 years earlier. Meanwhile, despite the high SPI,
the thiourea had been reduced to 25 mg. daily. May 29 she was admitted to the hospital
with herpes zoster of the right supraorbital region. Since her earlier admissions she
had gained much weight. She was again given 210 mg. of thiourea daily. The tempera-
ture on admission and for the next 10 days was slightly elevated, but returned to
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normal on June 9, 2 days before thiourea was discontinued in spite of a persistently
high SPI. The patient did not appear hyperthyroid, although she perspired rather
profusely. Her serum cholesterol was, however, persistently low. The blood pressure
was normal after the first admission. The blood count remained normal throughout
her illness.
After discharge she took thiourea and iodine irregularly. July 2 she was complaining
of intermittent pain in the right side of the abdomen. She did not seem hyperthyroid.
September 8, having taken 140 mg. of thiourea and 15 drops of Lugol's solution daily
meanwhile, SPI was 11.8 y per cent, though symptoms of hyperthyroidism were
minimal. November 17, on the same medication, recovering from a mild coryza, she
complained of slight swelling in the submaxillary region for a month. No objective
equivalent was noted. Her skin seemed slightly dry, but there were no other evidences
of hyperthyroidism.
The fever in this case can not be indisputably attributed to thiourea.
Although at times the two seemed to be correlated, this relation was in-
consistent. In every instance some entirely unrelated cause could be found
for the fever. The SPI remained consistently elevated without comparable
clinical signs of hyperthyroidism. It can not, however, be altogether dis-
counted; it was associated with low serum cholesterol. The pulse was mis-
leading because of the presence of fibrillation. Even at the height of her
hyperthyroidism, when the basal metabolism was +29 per cent, the pulse
rate was only 82.
B90726 (MS), female, born in 1886, was first admitted to the hospital March 28,
1948, because of an attack of acute pulmonary edema. She had had hypertension for
5 or 10 years and anginal attacks for 1 year. She was poorly nourished, acutely dis-
tressed and apprehensive, with pulse 96, blood pressure 180/90, heart greatly enlarged
and fibrillating, fine moist rales at the bases of both lungs, enlarged liver, and slight
pitting edema of the legs. Her skin was notably soft and smooth and she had a nodular
goiter of moderate size. She was given digitalis and subsequently quinidine for recur-
rent episodes of rapid fibrillation. On March 31 her SPI was found to be 13.0 'y per
cent. Her subsequent course is illustrated in Chart 3.
Lugol's solution, 20 drops daily, was begun on April 1 and on April 8, 75 mg. of
thiourea were added. On this regime she improved markedly. April 30 the thiourea was
increased to 140 mg. May 16 she developed stiffness in her neck and pain in her knee.
When admitted to the hospital on May 19 her temperature was 101.2°, pulse 112, blood
pressure 224/124 to 168/90, her neck was held stiffly, the heart was enlarged with
a variable rhythm, the lungs were clear, the left knee was swollen and warmer than
the right. In the course of the day the temperature rose to 104.20, the pulse to 140.
Spinal fluid and cultures of blood and urine were negative. Her leucocyte count was
24,000 with 80 per cent of polys; her urine contained a trace of albumin. The throat
culture yielded a heavy growth of f8-hemolytic streptococci. SPI on May 21 was only
6.7 y per cent. Thiourea was discontinued for 2 days and then resumed in doses of
75 mg. daily. Penicillin was given. The temperature and tachycardia continued, though
gradually diminishing, through June 10. The thiourea was discontinued on June 3,
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CHART 3. The two upper horizontal lines define the limits of variation of normal
SPI, the lowest horizontal line the upper limit of normal rectal temperature. During
the second, fourth and sixth of the periods separated by double vertical lines, while
the subject was an outpatient, the time scale is contracted.
pyribenzamine being given. Shortly after admission the liver was found to be consider-
ably enlarged and tender, serum cholesterol extremely low with an increased ratio of
free to total cholesterol, and cholesterol flocculation 4+, suggesting profound disorder
of liver function. After her temperature became normal her pulse remained elevated,
her appetite poor, and wasting continued. SPI on June 21 was 9.2 'Y per cent so thiourea
was resumed. She took 75 mg. daily until July 12 without recurrence of fever. At that
time, because wasting continued and the SPI had risen to 13.9 'y per cent, the dose
was increased to 150 mg. daily. On July 30, although she was steadily improving and
there were no signs of intoxication, she was changed to 300 mg. of propylthiouracil.
She was doing well on this regime at home until she stopped taking digitalis. August
30 she was again admitted to the hospital in a state of acute pulmonary edema which
cleared rapidly upon resumption of digitalis. She was discharged again on September
6. While in the hospital she was given on two successive days, without reaction, 75 and
140 mg. of thiourea respectively. On this admission she again had a polymorphonuclear
leucocytosis. After discharge, on digitalis, Lugol's solution, and propylthiouracil she
did remarkably well; but it was necessary to increase the dose of propylthiouracil to
400 and then 450 mg. daily because of a rising SPI and recurrent symptoms of hyper-
thyroidism. While in the hospital on both second and third admissions she had slight
glycosuria at times and postabsorptive hyperglycemia on several occasions. In the
latter part of 1948 constant glycosuria, persistent hyperglycemia, and diabetic symptoms
compelled administration of insulin. On October 14 she was given, for test purposes,
210 mg. of thiourea with an additional 70 mg. the next morning. This did not provoke
fever or any other untoward reaction.
In this case no clear connection could be established between the thiourea
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and the arthritis, which seems to have originated from a hemolytic strepto-
coccal infection of the throat.
B73103 (MJS), female, born in 1874, had had one pregnancy which ended in early
abortion. She had suffered from urinary frequency without dysuria for many years.
In 1936, because she was suspected of hyperthyroidism, she was given iodine for several
months. About the middle of 1943 nervousness, irritability, and loss of weight began.
When seen in June, 1944, she had definite exophthalmos, the characteristic skin texture
and moisture, tachycardia, tremor and enlargement of the thyroid. The heart was
overactive, but not enlarged, the lungs clear, the liver down 5 cm. There was no
edema. The basal metabolism was +43 per cent, SPI 8.9 y per cent. Her course is
illustrated in Chart 4.
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CHART 4. The two upper horizontal lines define the limits of variation of normal
SPI, the lowest horizontal line the upper limit of normal rectal temperature. During
the period to the left of the double vertical line, while the subject was an outpatient,
the time scale is contracted.
She was given daily 15 drops of Lugol's solution and 400 mg. of thiourea, which
was reduced to 200 mg. about a month later when the basal had fallen to +5 per cent,
SPI to 5.2 'y per cent, and symptoms of hyperthyroidism had ceased. Shortly after
this Lugol's was discontinued. In September the SPI had fallen to 3.3 oy per cent,
in October her eyes were puffy although the basal metabolism was still +11 per
cent; in November she was definitely myxedematous with SPI 0.6 Sy per cent,
although the basal metabolism was 817 -per cent. When thyroid was given without
discontinuing thiourea, the basal metabolism rose to +37, SPI to 9.3 Sy per cent, and
her weight fell. Five weeks later doses of both thyroid and thiourea were halved. By the
end of September, 1945, the basal metabolism had fallen to +21 per cent, SPI to 6.0 y
per cent. Meanwhile, as early as July, while she was still receiving 200 mg. of thiourea
daily, painful red spots which tended to ulcerate had appeared about her ankles,
accompanied by a slight temperature.
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She was admitted to the hospital October 4, poorly nourished, with slight exoph-
thalmos, pulse 96, blood pressure 144/80. There were small ulcerative lesions over the
feet and the lower parts of the legs, surrounded by erythema. Cultures from these
lesions as well as the blood were negative, as were agglutinations of all kinds. She had
some evidence of impaired liver function and a polymorphonuclear leucocytosis that
rose as high as 16,000. Discontinuation of both thiourea and thyroid from October 12
to 19 had no apparent effect on fever or skin lesions. At the end of this period thiourea
was resumed in higher dosage, this time with Lugol's solution. The thiourea was
again reduced to 70 mg. on November 7 because SPI had fallen to 4.6 -y per cent.
November 25 the temperature fell and remained normal thereafter, with the exception
of 2 days, despite continuation of thiourea, until her discharge on January 27, 1946.
By that time all the skin lesions were healed. She was followed in the dispensary until
April 23. At this time SPI 'had risen to 11.7 -y per cent. Presumably 70 mg. of thiourea
were insufficient. She was not seen again. It was learned that shortly after her last
visit to the dispensary she fractured her femur (x-rays in the hospital had revealed
general osteoporosis).
This case is peculiarly baffling. It is reported that at the onset her rash
cleared when she discontinued thiourea for a short time, but there were no
observations to support this. At the time of admission she had received only
small doses of the drug, or none for a considerable interval. In the hospital
interruption of the drug for a week had no demonstrable effect. Increasing
the dose to 210 mg. daily was equally ineffective so far as the rash was
concerned, though it did reduce basal metabolism and SPI. Rash and
temperature ultimately subsided under the same dose of thiourea with which
they began.
C2869 (AM), female, born in 1896, had anterior poliomyelitis in 1906. In 1925,
because of a residual deformity, her Achilles tendons were lengthened. Since that time
her ankles have been large. She suffered from hay fever. Some time in 1945 she noted
a swelling in her neck and began to lose weight. When first seen on September 11,
1946, she had ruddy, moist skin, no exophthalmos, enlargement of the thyroid, pulse
106, blood pressure 152/88, an enlarged heart with a harsh precordial systolic murmur,
and large shapeless legs that did not pit. The basal metabolism was +40 per cent. SPI
was 8.4 -y per cent. Her course is illustrated in Chart 5.
She was given daily 15 drops of Lugol's solution at once and 75 mg. of thiourea a
week later. Because she did not respond, the dose of thiourea was increased suc-
cessively to 140 and, on August 7, 1947, to 210 mg. At this time, following a sore
throat, SPI had risen. On the higher dose, by September 24, nervousness had
diminished. A week later she noticed the gradual onset of malaise, chilly sensations,
generalized aching and feverish feelings, occasional frank chills. About the same time
a rash appeared on both ankles. She was admitted to the hospital on October 6, flushed
and hot, with throat injected, a few petechiae on her hard palate, slight bilateral
costovertebral tenderness, slight pitting edema of both legs and ankles, a petechial
rash extending from the ankles to the middle of the legs, temperature 102.40, pulse
108, blood pressure 150/100. The blood culture was negative, the throat culture innocent.
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CHART 5. The two upper horizontal lines define the limits of variation of normal
SPI, the lowest horizontal line the upper limit of normal rectal temperature. During
the first, third and fifth of the periods separated by double vertical lines, while the
subject was an outpatient, the time scale is contracted.
She was given penicillin at once and, on the suspicion that the rash might be toxic,
thiourea was discontinued 4 days later. In the course of the next 9 days the tempera-
ture subsided, pains ceased, and the rash faded. On October 4, because SPI had risen
from 6.6 to 11.3 y per cent, thiourea was resumed in doses of 50 mg. daily. The
temperature on 3 days rose to 100.6 to 100.80 but became and remained normal when
the dose was raised to 75 mg.
After discharge, on November 1, through some error she took 210 mg. instead of
75 mg. of thiourea. By November 14 SPI had fallen, her skin was dry, there were no
signs of rash, but she complained of vomiting and occasional chills and had tachycardia.
Thiourea and Lugol's were discontinued on December 9. December 17 she had con-
tinuous aching in thighs and legs, chilly sensations, and a stiff neck. The muscles in the
back of her neck were tender and her legs were tender and hot. She was admitted to
the hospital with a temperature of 102.4°. Symptoms and signs subsided without specific
treatment in a few days and remained in abeyance until her discharge on January 1,
1948, although she was given first 75 and then 125 mg. of thiourea. With the febrile
episodes on both occasions she had a polymorphonuclear leucocytosis which reached
a peak of 20,800.
Early in February she again developed pain and brawny swelling of one leg. Because
SPI had risen to 11.3 y per cent, thiourea was increased to 140 mg. By the end of
another week the signs of inflammation in the leg had subsided. In April, when SPI
had fallen to normal, she was given digitalis for exertional dyspnea and edema of
the legs.
July 15 a maculopapular, erythematous, intensely pruritic rash appeared over her
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arms and legs. When she was seen a week later, 150 mg. of propylthiouracil were
immediately substituted for the 140 mg. of thiourea she had been receiving. The rash
subsided within a few days. On August 17 the dose of propylthiouracil was reduced to
50 mg. daily. On this regime she has continued free from symptoms and working
full time.
During her first and second admissions to the hospital her urine occasionally
contained sugar. A fasting blood sugar on October 7, 1947, was 145 mg. per cent.
Intravenous glucose tolerance tests on various occasions yielded the following results:
October 8, 0 hrs. 161, 2 hrs. 162; October 20, 0 hrs. 95, 2 hrs. 83; December 18, 0 hrs.
99, 2 hrs. 119 mg. per cent.
In this case the relation of thiourea to rash, pains, and temperature was
capricious. The reactions resembled those seen in the periodic infections of
thrombophlebitic legs with lymphatic obstruction. On at least one occasion
they disappeared without any change of the dose of thiourea and on two
occasions persisted for considerable periods after thiourea had been dis-
continued. On the first admission thiourea was resumed, in small doses to
be sure, only 72 hours after subsidence of the temperature, without un-
toward symptoms. The subsequent rash was of an entirely different char-
acter, more suggestive of an allergic reaction. Whether it should be
attributed to thiourea it is impossible to say. In the face of the mere
possibility that the drug might be responsible it seemed unjustifiable, so
long as a substitute was available, to risk prolongation of the patient's
distress.
A6280 (HM), female, born in 1878, reputedly had malaria in 1890, a dropsical
condition of some kind in 1906, and in 1908 was told that she had heart trouble. In
1932 a radical mastectomy was performed for carcinoma of the left breast with
metastases. At that time she also admitted nocturia 3 to 5 times a night. She was
obese, her pulse 90, blood pressure 170/78. Physical and laboratory examinations
revealed no other abnormalities. In 1943 she began to lose weight; in 1944 she noticed
increasing nervousness and appetite, intolerance to heat, excessive perspiration and
tremor. About July of 1945 dyspnea on exertion began; on October 3 she was seized
with sudden palpitation and a choking sensation. On admission to the hospital next
day she was breathless, with temperature 99.4°, pulse 100, respirations 32, blood
pressure 200/70. The thyroid was enlarged and there was a fine tremor of the hands,
but no exophthalmos. The heart was slightly enlarged, with a systolic murmur; the
lungs were clear. The basal metabolism was +56 per cent, SPI 12.7 Y per cent. Her
course is illustrated in Chart 6.
November 3 she was given intravenously 1 gm. of thiourea. November 5 she received
140 mg. and after that 210 mg. daily by mouth, without Lugol's solution. November 8
a slight urticarial rash appeared over the left forearm. It was learned that she had been
subject to such rashes for many years. For the next few months the basal metabolism
and SPI fluctuated considerably, although the dose of thiourea remained unchanged.
For a time she lost a considerable proportion of her hair, suggesting myxedema,
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CHART 6. The two upper horizontal lines define the limits of variation of normal
SPI, the lowest horizontal line the upper limit of normal rectal temperature. During
the first, third and fifth of the periods separated by double vertical lines, while the
subject was an outpatient, the time scale is contracted.
although both basal metabolism and SPI were within normal limits. In September,
1947, she noted weakness, anorexia, nervousness and sweating for a period, following
a serious illness of her husband. By the middle of November she was forced to go to
bed. A month later she reduced the thiourea to 140 mg. daily because of difficulty in
swallowing solids, thirst, dyspnea, orthopnea, and palpitation.
January 9, 1948, she entered the hospital with temperature 1020, pulse 120 and
irregular, and blood pressure 178/80, dulness at the left base of the lungs, with riles
at both bases, venous pressure 50 mm., and circulation time 16 seconds. X-ray revealed
pleural effusion and thickening at the left base with questionable infiltration of the
left lower lobe; electrocardiogram showed a moderate left axis shift and multiple
premature auricular beats. She was given digitalis. Blood culture, agglutinins, etc.
were negative; the blood count was not remarkable; the urine was innocent except for
slight glycosuria for a short period. The temperature fluctuated capriciously. January
20 it fell to normal while she was still taking 210 mg. of thiourea. It remained down
for the next 3 days in which she received no thiourea or only 70 mg., rising again for
2 days when 210 mg. were given. It was again normal on January 26 when she took
70 mg., but rose to a peak of 102.40 on the 28th, the second day without thiourea. When
thiourea and Lugol's solution were both resumed, the temperature gradually subsided
again, but during this period she developed successively a transitory conjunctivitis
and an erythematous rash on her thigh. February 13, since SPI had fallen to 5.4 'y
per cent and the pulse was slow, the dose of thiourea was reduced to 140 mg. daily.
She was discharged on February 24 with a normal temperature.
About February 29, while going to the bathroom, she fainted. About March 7 a rash
appeared on her knees and elbows. She was readmitted to the hospital on March 13
with temperature 99.60, pulse 84, blood pressure 110/60, drowsy, with thick speech,
but oriented. Her face looked puffy and there were numerous hemorrhagic papular
lesions about the knees, ankles, and elbows. Her heart was slightly enlarged and there
were again signs of fluid at the left base. The temperature next day rose to 1030,
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though she received only 70 mg. of thiourea, which was then discontinued entirely.
Her chief complaints were weakness, dizziness, and pains on moving her legs. During
the next 10 days the temperature fell and symptoms diminished. March 2 Lugol's solu-
tion was resumed. From March 23 to April 5 she was afebrile, but SPI rose from 5.4
to 9.2 -y per cent. March 7 and 8, when she was given 75 mg. of thiourea, the tempera-
ture rose to 102.2 and 102.40, falling again in the course of the next 24 hours. At the
same time an ulcer appeared on her gum. During the succeeding month, without
thiourea, SPI rose to 13.2 y per cent, the pulse became more rapid, she had irregular
spikes of temperature to 101' and another ulcer appeared in the mouth. May 12
propylthiouracil in doses of 75 mg. daily was begun. The temperature rose on the
12th and 17th 'to 100.8 and 1010 respectively, without symptoms. She was discharged
on the 18th.
May 25, because of increasing exertional dyspnea and tachycardia and some edema
of the legs, the digitalis was increased to 0.2 gm. daily. June 4, because of nervousness,
clammy skin, and tremulousness, the dose of propylthiouracil was raised to 150 mg.
daily. On this medication she has continued without further symptoms of importance
and has regained an apparently euthyroid state.
In this case, on at least one occasion, there seems to have been a sharp
febrile reaction to small doses of thiourea; but, with this exception, it is
hard to establish a direct relation between the drug and fever or other
symptoms. Discontinuation of thiourea for long periods on two occasions
did not eliminate symptoms, although during her second admission these
subsided while she was taking the drug. The nature of the recurrent pul-
monary and pleural reaction was never definitely determined. It seems to
have begun with a pneumonic process. Despite the signs of effusion,
repeated thoracenteses yielded no fluid. She resembled the other patients
who have been discussed in the rapidity with which SPI rose when thiourea
was discontinued. Like them she did not appear to be unresponsive to the
drug when it was resumed. When she became asymptomatic, her weight
rose, while SPI and pulse fell, on a far smaller dose than that which had
earlier been required to control her symptoms. Although it was not un-
equivocally proved, this must be regarded as a presumptive example of
intoxication with thiourea.
B2143 (PC), female, born in 1920, was treated in 1940 for an indurative acne with
local measures and injections of progesterone. In the summer of 1945, despite a
ravenous appetite, she began to lose weight, became increasingly nervous and intolerant
of heat, and developed tachycardia. Her thyroid enlarged and her menses became
scanty. Her basal metabolism proved to be +30 per cent. Subtotal thyroidectomy was
performed. After this she regained some weight, but irritability, nervousness, and
hypermetabolism continued. A year later dyspnea on exertion was added. When seen
on May 10, 1946, she had a palpable goiter, exophthalmos, a fine tremor, moist skin,
a slightly enlarged heart with an apical systolic murmur, pulse 120, and blood pressure
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140-150/80. Her basal metabolism was +39 per cent, SPI 8.1 -y per cent. Her course is
illustrated in Chart 7.
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CHART 7. The two upper horizontal lines define the limits of variation of normal
SPI, the lowest horizontal line the upper limit of normal rectal temperature. During
the first and third of the periods separated by double vertical lines, while the subject
was an outpatient, the time scale is contracted.
On 15 drops of Lugol's solution and 15 mg. of thiourea daily, pulse and basal
metabolism diminished; but SPI, after an early drop, rose again to hyperthyroid levels,
where it remained. Her weight also failed to rise. In December the dose of thiourea
was increased to 50 mg. Both basal metabolism and SPI fell to normal, but still her
weight did not rise. May 31, 1947, tremor and sweating had ceased, but her palms were
peeling which was attributed with some uncertainty to epidermophytosis. At the end
of July she complained of watering eyes and orthostatic edema of the ankles without
dyspnea. The urine was negative. Basal metabolism, SPI, and pulse were still normal.
By November her weight had fallen further and SPI had risen to 9.8 Y per cent. In
January, 1948, she began to suffer from pains, especially in the knees. In the middle of
February a painful swelling of the left calf disabled her for 3 or 4 days. At the end
of the month she had pains in her hands, elbows, and shoulders. Meanwhile SPI had
risen and her weight had fallen further. March 12 canker sores appeared in her mouth.
March 19 she was admitted to the 'hospital in an emaciated state, with marked
exophthalmos, acne of the face, pustules over the buttocks, a granulating ulceration in
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the anal fold and small ulcers on the sides of her tongue, an enlarged heart with
a rumbling systolic murmur at the apex, a presystolic murmur just to the left of the
apex, and a friction rub just to the left of the lower part of the sternum. This last
was noted on several subsequent occasions. Her lungs were clear. There was no edema.
The liver seemed to be enlarged. Her temperature was 100.20, pulse 120, blood pres-
sure 120/66. Her skin was moist and satiny. Motions of the shoulders and elbows
caused pain. The blood count was not extraordinary. Blood culture and antistreptolysin
test were negative.
She was given aspirin and the dose of thiourea was increased to 150 mg. Neverthe-
less, and although she had received no organic iodine compound, SPI on March 23
proved to be 46.4 y per cent and on the 25th was 44.8 y per cent. Her weight had
fallen further. The temperature touched 100° twice in the first 6 days, but when aspirin
was discontinued on the 26th, it rose to 100.8 or 1010. March 26 she complained of
substernal pain. This was one of the occasions when a pericardial friction rub was
heard. Pains, mouth ulcers, and skin lesions continued to appear.
April 2 thiourea was discontinued. Four days later her temperature, which had been
gradually mounting, rose sharply to 103.40, to fall precipitately to normal 2 days
later. At this time her cephalin flocculation test was 4+ after 48 hours, her meta-
carpophalangeal joints were painful, shoulders and knees ached, her right elbow was
red and painful, her right wrist was swollen, and she developed subcutaneous nodules
over the right elbow and about her knees. As the temperature subsided all symptoms
and signs improved, but she had received aspirin during this period. April 13 she
complained of pain in the right upper quadrant of the abdomen. The liver was found
to be diffusely enlarged and tender.
April 19, when she had been afebrile for 11 days, she was given 50 mg. of propyl-
thiouracil without obvious effect. The following day, after 70 mg. of thiourea, the
temperature rose sharply to 1020 and the next day the pains in the elbows and
shoulders became exaggerated. The febrile reaction persisted only 48 hours. In the
following 3 days new skin lesions appeared on her face, lip, and buttock, and a fresh
nodule on her finger. From that time through May 19 she continued to have recru-
descences of joint pains and new oral lesions and subcutaneous nodules. Beginning
on May 16 propylthiouracil was given in increasing doses up to a daily dose of 75
mg. on the 18th, without especial untoward symptoms. A new lesion did appear on
her tongue on the 19th. During her course in the hospital she had a polymorphonuclear
leucocytosis that on one occasion was as high as 14,500.
June 11 she still had some pains in her knees with slight effusion in the right, as
well as a small ulcer on the border of her tongue. July 15 her knees still ached, and
ulcers continued to appear in her mouth. August 10 symptoms had almost disappeared,
but on the 16th she had an ulcer on her third left toe, on the 23d nodules on the tips
of two fingers. These all disappeared fairly rapidly. When seen September 14 a new
nodule had appeared on her thumb, had opened, discharged, and healed. On the 20th
she had a crop of acneiform pustules on her arms and legs as well as on her face,
which resembled the lesions that had previously been termed nodules. At this time
Lugol's solution was stopped, but November 15 the acne was unimproved. She appeared
euthyroid. Except for the acne she has been free from symptoms since that time.
The course of the SPI in this case is altogether unique. Attention has already been
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change of therapy. Because of the high SPI the dose of thiourea was first doubled
to 150 mg. per day for 12 days. The drug was then discontinued for reasons mentioned
above. At the end of 5 days SPI was found to have risen to the unprecedented figure
of 71.5 y per cent. Thereafter, without medication, it gradually receded as fever and
other symptoms subsided, to reach 34.4 -y per cent by May 10. A month after propyl-
thiouracil was given it had fallen further to 22.2 'y per cent. At this time the patient
still had symptoms and signs of hyperthyroidism, but seemed otherwise well. With
further improvement and disappearance of evidence of excessive thyroid activity, SPI
ultimately, on November 15, had fallen to 6.0 y per cent, an entirely normal value.
This case is distinguished from the others in that the patient was a
young adult without evidences of antecedent vascular disease. The initial
elevation of systolic blood pressure must be discounted, since the pressure
was subsequently consistently normal. Furthermore, the symptoms began
after small doses of thiourea. As in the previous case, on one occasion a
comparatively small dose of thiourea appeared to precipitate a striking
febrile reaction with exacerbation of symptoms. Similar symptomatic
exacerbations without fever occurred, however, at intervals throughout a
period of weeks during which she received no thiourea. The clinical pattern
and course of the disease were indistinguishable from that of rheumatic
fever or one of the allied disorders. The evidence that the symptoms in this
case were referable to thiourea is less convincing than it was in the two
preceding cases. They subsided only long after propylthiouracil had been
substituted, and then only stepwise. The arthritis outlasted the temperature
by a considerable interval. The lesions of the mouth continued still longer.
It is hard to say when the skin lesions ceased because of the confusing
presence of an acne of unusual distribution. This, it will be recalled, had
been noted and treated in 1940 when the patient also complained of pains in
her neck and chest.
Five patients died while receiving thiourea or propylthiouracil. Autopsies
were obtained on all.
C6107 (MW), female, born in 1893, had a thyroidectomy for hypertension in 1919,
after preliminary treatment with radium. Gradual recurrence of symptoms in 1930
led to a second operation in 1934 that gave conspicuous relief, though it left residual
fatiguability, weakness, and palpitation. In 1945 she was given injections by her
physician for hot flashes, although her menses had not ceased. About this time her
goiter reappeared, accompanied by increased palpitation and fatigue, with tremor,
sweating, shortness of breath, and loss of weight. Her menses gradually ceased in
1947. In the fall of that year, following a cold, she developed a persistent cough. About
1945 she began to have nocturia 2 or 3 times a night. No history of rheumatism could
be elicited.
When seen, January 8, 1948, she was wasted (her weight had fallen from 145 to
105 pounds), tremulous and restless, with moderate exophthalmos, temperature 1010,
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pulse 120 and totally irregular, blood pressure 180/75. She had a large goiter, involv-
ing especially the left lobe of the thyroid. The heart was grossly enlarged and fibril-
lating, riles were heard at the bases of both lungs and in the right axilla, the liver
was down 2 fingerbreadths, the spleen 2 to 3 fingerbreadths. X-ray revealed enlarge-
ment of the left auricle and ventricle and minimal pulmonary congestion. The basal
metabolism was +87 per cent, the serum precipitable iodine 30.2 'y per cent. She was
immediately digitalized and given 15 drops of Lugol's solution and 210 mg. of thiourea
daily. By January 21 the SPI had fallen to 14.2 y per cent, the pulse to 96, sweating
and tachycardia had diminished. February 25 improvement had continued. SPI was
8.1 y per cent, though the basal metabolism was still +54 per cent and her weight
had not risen.
At this time her daughter had mumps and the patient was found to have non-tender
enlargement of the right submaxillary gland. Two days later she developed pains in
the legs, later spreading to the arms, with red and swollen joints. These improved for
a week, when she developed a "pneumonic condition" for which she was given injec-
tions of penicillin 4 times a day for 2 weeks. Again her condition improved; but on
March 14 her fever rose sharply, she became delirious, unable to take food, extremely
nervous and sleepless, and incontinent of urine and feces. Lugol's solution had been
discontinued March 4, thiourea, March 13. Digitalis had been continued.
When admitted to the hospital, March 18, she was delirious and so hyperactive
that examination was impossible. Her temperature was 1020, pulse 124. Twelve
hundred cc. of normal urine were withdrawn by catheter from a distended bladder.
The next morning her temperature was only 100.20, pulse 132 to 100, respirations 30,
blood pressure 140/60. She was emaciated, feeble, trembling all over. She had marked
exophthalmos with conjunctival injection. The precordium was heaving, the heart
totally irregular with tumultuous sounds, a systolic thrill and murmur. The bladder
was again distended. The left knee was painful and swollen. In the afternoon she
suddenly went into a state of collapse, with cold clammy feet and hands, fine and
coarse rfales all over both chests, pulse 160, and blood pressure 140/90. She died
before anything could be done. The leucocyte count was normal, but she had a slight
secortdary anemia. The serum precipitable iodine was not determined during her
terminal illness.
Anatomical findings at autopsy: Hyperplastic thyroid remnant (105 grams);
segmental necrosis of coronary, renal, adrenal, splenic, and pancreatic arteries; hyper-
trophy and dilatation of the heart; confluent focal pneumonia (mixed infection).
Subsidiary findings: An occasional lesion in the liver, lungs, and lymph-nodes
suggesting Boeck's sarcoid; minimal cortical gliosis.
Microscopically the thyroid was made up of hyperplastic and atrophic follicles with
increased interstitial lymphoid and connective tissue.
There was practically no arteriosclerosis of the aorta or of the great arterial trunks.
Striking mural changes were present in the small muscular arteries of the heart,
kidneys, adrenals, spleen, and pancreas. Fibrinoid necrosis of the media was prominent.
An inflammatory cellular exudate accompanied this medial necrosis, forming accumula-
tions of leucocytes within or around the vessel wall. No eosinophiles were found.
Occasionally elevation of the endothelium had occurred but no thrombi were observed.
Occasional sites of fresh collagen replacement were present in the media, but other
than this there was no evidence of proliferation or healing in the vessels. The lesions
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were all approximately equal in age. Nearly every interlobular artery in the kidneys
and nearly all the smaller arteries of the pancreas were involved. In the other organs,
somewhat fewer arterial changes were present.
There was no evidence of old or recent rheumatic carditis. The sarcoids observed
were small and apparently in the healing stage. The salivary glands were not
examined. The focal pneumonitis was fresh and widespread in the lower lobes.
The autopsy findings in this case are peculiarly at variance with the
clinical course. For the last 30 years of her life the patient had suffered
from recurrent hyperthyroidism. In the last 3 years symptoms of cardiac
embarrassment appeared. In the fall of 1947, 3 or 4 months before death,
following a respiratory infection, these became worse. When seen in Janu-
ary she presented the picture of extreme hyperthyroidism and congestive
failure with an extraordinarily high SPI. Her response to thiourea and
iodine was prompt and highly satisfactory until the onset of her final illness.
This again may have been an infection, characterized by pneumonia and
arthritis, which subsided after penicillin. With a recrudescence 2 weeks later
she went into a state that, had she not received thiourea, might well have
been termed a fatal "thyroid storm." So desperately ill was she and so brief
was her course in the hospital that there was no time for diagnostic nor
therapeutic measures. Except for the progressive increase in severity and the
appearance in the last illness of arthritis there is nothing to distinguish the
reaction of the patient to her various infections. At autopsy there was a con-
fluent pneumonia and a widespread acute vascular reaction, but no adequate
explanation for the earlier cardiovascular symptoms which were unmistak-
able and preceded the administration of thiourea. Although the drug may
have contributed to the denouement, this background can not be neglected;
nor can the possibility be excluded that infection rather than thiourea was
responsible for the illness as well as its fatal outcome.
B7801 (GB), female, born in 1885, was married in 1905 and gave birth to an only
son the following year. In 1925 she went into an acute depression following an opera-
tion for retroversion of the uterus. Early in the spring of 1940 she became more tense
and nervous than usual. In August she was admitted to the Psychiatric Ward in a
state of extreme agitation and depression and bromidism. She was discharged, im-
proved, after a month. In August of 1941 she was again admitted in a similar state.
This time she remained in the hospital for 2 months. March 1, 1945, she was admitted
for the third time. On all these occasions her pulse in the hospital had been abnormally
rapid, tremors and motor activity had been noted, and her blood pressure had been
variably elevated. On each occasion the temperature was elevated at the outset. During
this 1945 admission, the SPI on March 6 was found to be 12.6 -y per cent. Lugol's
solution was given at once. Her course is illustrated in Chart 8. By March 19, after
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13 days of medication, tachycardia and other symptoms had disappeared and the serum
precipitable iodine had become normal. For some reason, medication was discontinued
after her discharge.
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CHART 8. The two upper horizontal lines define the limits of variation of normal
SPI, the lowest horizontal line the upper limit of normal rectal temperature which is
assumed to be 1000 by rectum, 990 by mouth. The shifting position of this line during
the second day in the hospital indicates that the temperature was taken for some periods
by mouth and for others by rectum. The vertical arrows at the top of the figure
indicate electric shocks.
Beginning May 2 she became increasingly disturbed until her readmission on May
16, when her pulse was 120, her blood pressure 180/80, and she was in an unmanage-
able state. Her serum precipitable iodine was 13.6 y per cent. Lugol's solution was
resumed. By June 9, though the pulse rate had fallen somewhat, the SPI was still
13.8 y per cent and there had been little clinical improvement. Thiourea was, therefore,
given, 50 mg. daily at first, increased to 200 mg. after a week. July 25 the psychotic
state was unrelieved. An elevated temperature was noted at this time (it had probably
preceded this, but had not been recognized because oral temperatures had been taken).
July 28 some edema of the ankles was noted, although she seemed dehydrated. It was
impossible from this time on to evaluate her physical condition owing to her mental
state. The thiourea was increased to 420 mg. from July 21 to 31 because of the striking
tachycardia and high SPI. At the end of this time the previous dose was resumed.
Two weeks later the serum precipitable iodine had fallen to 8.2 'y per cent; subse-
quently it descended to 7.0 'y per cent. Fever, tachycardia, and edema, however,
persisted. Before this time tube feeding had been instituted, as a result of which her
throat became quite sore. She had also been subjected to electric shocks during the
period of high thiourea dosage. She deteriorated steadily until her death on October 7,
which was preceded by a short period of steadily rising fever. She had a variable
leucocytosis towards the end of her course.
Anatomical findings at autopsy: Nodular hyperplasia of thyroid (60 grams);
generalized arteriosclerosis and arteriolosclerosis; coronary arteriosclerosis; cardiac
hypertrophy and dilatation; scars of myocardium; thrombi in pulmonary vessels;
infarcts of lungs.
Subsidiary findings: Pulmonaryemphysema; chronic gastritis; leiomyomas of uterus.
The thyroid follicles were composed chiefly of dilated acini containing much colloid,
suggesting iodine effect. Several areas of hyperplastic epithelium were present as well.
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Sclerosis of the aorta was severe. In the arch a small mural thrombus was present.
The underlying intima was not only fibrous and thickened but was edematous and
contained a diffuse cellular exudate of lymphocytes, polymorphonuclear leucocytes, and
plasma cells. Sclerosis of the visceral arterioles was also severe. It was of the sub-
endothelial hyaline variety, without evidence of any acute process. The interlobular
vessels of the kidney and the larger renal vessels were particularly involved, as were
the peri-adrenal and pancreatic arterioles. The kidneys were not scarred, weighing
together 325 grams. The coronary vessels were calcified but patent. There was
lipomatosis of the myocardium besides the focal scarring. The mitral valve leaflets
were thickened, with fused chordae tendineae. Beyond this there was no suggestion of
old or recent rheumatic carditis. The pulmonary infarcts were recent.
In this case arterial disease had obviously preceded the final illness and
administration of thiourea, although little clinical evidence of such a condi-
tion had been found. The mental state of the patient prevented a satisfactory
clinical analysis. It is quite uncertain whether fever followed or preceded
administration of thiourea.
B54264 (ER), female, born in 1903, was seen in the prenatal clinic May 1, 1944, in
the 7th month of her 6th pregnancy, with blood pressure 140/90, urine negative.
Between this time and her delivery on July 30 her weight rose from 152 to 176 lbs.,
with the appearance of some edema of the ankles, but no further hypertension. One
blood pressure in the hospital was 150/90. A catheterized urine was normal. Her
thyroid at that time was reported not enlarged.
May 31, 1945, she was admitted to the hospital, complaining of swelling of the
neck, loss of weight, extreme nervousness, occasional difficulty in breathing, and
orthostatic swelling of the ankles. She had a staring expression, -fine tremor of the
hands, a diffusely enlarged thyroid, moist skin, lenticular opacities, pulse 120, blood
pressure 140/60. Her basal metabolism was+55 per cent, SPI 14.3 -y per cent. Blood
count and urine were normal. Her course is illustrated in Chart 9. By June 14 on rest
alone the basal metabolism had fallen to+48 per cent, the SPI to 9.0 y per cent. She
was given 15 drops of Lugol's solution and 200 mg. of thiourea daily. By the end of
July, much improved, her basal metabolism was+21 per cent, SPI 5.1 'y per cent.
Shortly after this, for no obvious reason and without change of treatment, pulse, basal
metabolism, and serum precipitable iodine rose for a short period to hyperthyroid
values. This hyperthyroid phase was preceded by a short hypothyroid episode.
April 9, 1946, she was admitted to the hospital for a cataract operation, with slight
tachycardia, but normal temperature. The day after operation her temperature rose
to 1010. From that day until her discharge on April 23 she had a low grade intermit-
tent fever, apparently associated with a laryngitis. The SPI the day before her dis-
charge was 7.1 y per cent. Between that date and December 20 it rose steadily to
reach the extraordinary figure of 46.0 y per cent.
Some time between June and August she began to suffer from pains in her joints,
without swelling or redness. She subsequently stated that these cleared up when she
stopped thiourea, recurring when she resumed the drug. She also said that her nervous-
ness returned when she discontinued the drug. Presumably, then, the treatment was
intermittent during this period, but there is no record of the interruptions. November
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the second, fourth and sixth of the periods separated by double vertical lines, while
the subject was an outpatient, the time scale is contracted.
12 an ulcer appeared over her left internal malleolus after an accidental kick. She was
admitted to the hospital November 19, with temperature 100.80, pulse 120, blood
pressure 142/84, hyperactive, with characteristic moist skin, slight exophthalmos, an
enlarged thyroid gland, a faint blowing aortic systolic murmur without signs of heart
failure, and sluggish ulcers over the left internal malleolus. The temperature rose
steadily to reach 103.40 on December 2, without further signs or symptoms, despite
a course of penicillin. Thiourea was discontinued for 5 days, beginning December 3, but
the temperature remained elevated and on the 8th she developed an ulcer on the
bridge of her nose, at the point of contact with the nosepiece of her spectacles. Blood
cultures and agglutination tests were all negative.
At this time, because of the high serum precipitable iodine and basal metabolism,
and extreme tachycardia, thiourea was resumed in doses that were increased to 420
mg. daily. Temperature and tachycardia persisted. She was discharged against advice
on December 24, at which time she complained of hoarseness. The urine had been
consistently negative. There had been a leucocytosis up to 13,500, with a normal
differential count.
She was readmitted to the hospital January 2, 1947, for 9 days, subjectively
improved, but still hoarse, with some nasal discharge, temperature 100.20, pulse 112,
blood pressure 106/70. The ulcers on her ankle were almost healed, but the lesions on
her nose persisted. Her liver was slightly enlarged. X-rays of the chest and abdomen
were again negative, blood counts and urines normal. The temperature again rose
almost daily to 103 or 1040. Although the serum precipitable iodine had declined, it
was still definitely above the normal range. She was seen again on February 2, 3, and
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first 2 occasions. She died at home on April 30. The white blood cell count was normal
except for a short leucocytosis up to 16 to 18,000 early in December 1946.
Anatomical findings at autopsy: Emaciation, diffuse enlargement and hyperplasia
of thyroid; ulcers of skin of extremities and nose; focal acute and organizing
pneumonia, lower lobes.
The thyroid gland weighed 45 grams and microscopically was composed throughout
of small acini with hyperplastic epithelium and little colloid. There was no anatomical
evidence of iodine effect.
Minimal aortic arteriosclerosis was present. No other lesions of arteries or veins
were found. Microscopically the ulcers of the skin revealed a superficial non-specific
chronic inflammatory process, without particular involvement of the regional vessels.
The heart weighed 225 grams and was not remarkable. There was no evidence of
hyperplasia of the parathyroids.
In this case autopsy disclosed no explanation for the extraordinary
cardiovascular disorders from which the patient had suffered and which
had been such a prominent feature of her final illness. The skin lesions,
which were nondescript in character, may have represented a reaction to
thiourea. The record, however, again indicates that an acute disorder,
accompanied by joint pains, and suggestive of an infection, precipitated an
uncontrollable outburst of hyperthyroidism. Unfortunately there is no
record of her course during the last 3 months of life.
B99489 (AP), female, born in 1896, was seen in the dispensary July 8, 1947. For 2
or 3 years she had been nervous and had experienced difficulty in maintaining her
weight, despite a good appetite. She had been given "nerve capsules" for hypertension.
In April or May, 1947, the nervousness increased, accompanied by tremor, tachycardia,
palpitation, breathlessness, and pruritus. She appeared well nourished, though she had
lost 30 pounds, extremely hyperactive, with a marked tremor, hot moist skin, a
slightly staring expression, slight enlargement of the thyroid and the heart, a widely
disseminated systolic murmur, but clear lungs, pulse 134, blood pressure 190/84. The
basal metabolism was +41 per cent, the SPI 14.1 y per cent. She was at once given
10 drops of Lugol's solution and 225 mg. of propylthiouracil daily. Her course is
illustrated in Chart 10.
By August 8 the basal metabolism had fallen to +2 per cent, the serum precipitable
iodine to 7.5 -y per cent, the pulse was in the 90's, and her weight had increased 3 kg.
She complained only of pain in her back and left hip which dated from an accident
in 1940. X-ray revealed a narrowed interspace between the 5th lumbar and 1st sacral
vertebrae and an anomalous transverse process on the former. At this time the
propylthiouracil was reduced to 150 mg. daily.
August 22 she complained of some residual nervousness, tremor, and fatiguability.
September 3 she complained of a slight cold. Her pulse was 90. From this time until
January 30, 1948, her SPI rose steadily to 14.0 -y per cent, her pulse became more
variable and she complained of increasing nervousness, although her weight rose
slowly. The basal metabolism lagged far behind the serum precipitable iodine and
signs of hyperthyroidism were not striking. On March 19, the serum precipitable iodine
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days on which she was seen.
being 12.2 ry per cent, 210 mg. of thiourea daily were substituted for propylthiouracil.
Some time in May she had hives for a few days, followed by an acute illness
characterized by sore throat, fever, severe general aches, prostration, and delirium.
A diagnosis of pneumonia was made by her family physician, who gave her both
sulfadiazine and penicillin. At the same time diabetes was discovered (there is no
previous record of a urine examination) and insulin therapy was begun, while Lugol's
solution and thiourea were discontinued. Lugol's solution was resumed on June 14
and thiourea on June 30. On June 14 she reported deterioration of vision. Her pulse
was 94, blood pressure 158/110, there were hemorrhages in both macular areas, the
urine gave a 1+ reaction for albumin, none for sugar (she was receiving 20 U. of
insulin per day), and contained a few white blood cells.
She apparently remained fairly well until July 13, when she had a severe insulin
reaction in which she became maniacal. The insulin was reduced to 10 U. of protamine
an July 14. That day she developed fever, generalized pains, and malaise. The next
day she was again given 10 U. of protamine insulin and thiourea was omitted. The
following day, July 16, she was brought to the Emergency Ward of the hospital,
having received no insulin, flushed, disoriented, and combative, with temperature 1020,
pulse 184, respirations 38, and blood pressure 205/105. She complained of great hunger
and thirst, took her dinner and drank ice water without vomiting. Her skin was hot
and dry, her neck somewhat stiff; she had moderate exophthalmos, an extremely
hyperactive heart and some rales at the base of the right lung.
Through failure to recognize the precise nature of her condition and consequent
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errors of therapy, she died in a state of shock the next morning. Discussion of the
details of this unfortunate episode are irrelevant and would divert attention from
the immediate subject.
During the earlier phase of her last illness she is reported to have had a severe
anemia. When admitted to the New Haven Hospital her red blood cell count was
8.6 million, hemoglobin 13.5 gm., white blood cells 48.2, with 30 per cent non-
segmented and 60 per cent segmented forms. Obviously she was in a state of extreme
hemoconcentration.
Anatomic findings at autopsy: Hyperplasia of the thyroid gland with areas of
marked involution; pancreatic fibrosis; widespread segmental necrosis of small arteries
in the thyroid, liver, gall bladder, spleen, omentum, bone marrow, and salivary glands;
pulmonary congestion and edema. There was moderate intimal arteriosclerosis of the
aorta and larger vessels, and a chronically inflamed Meckel's diverticulum.
The thyroid gland weighed 37 grams. It was nodular grossly. Microscopically,
connective tissue and lymphocytes were increased between groups of dilated acini.
Many of the acini were ;filled with homogeneous, eosinophilic colloid. Occasional
groups of small acini with high cuboidal epithelium and without colloid were present,
suggesting hyperplasia.
Changes in the small arteries throughout the viscera consisted of segmental medial
necrosis accompanied by cellular exudate involving in varying degree the three arterial
coats. The cellular exudate was composed of mononuclear cells and a few poly-
morphonuclear leucocytes. Accumulations of these cells were often present micro-
scopically in the periadventitial tissues. No eosinophils were found, although
subendothelial accumulations of exudate were observed. No thrombus formation had
occurred. The changes in the arteries described were all approximately in the same
acute stage, except those in the pancreas.
The sublingual and submaxillary glands were the seat of a diffuse acute interstitial
inflammation, which appeared to be an extension of the necrotizing process in the
arterioles.
Interstitial fibrosis of the pancreas was widespread with reduction of acinar and
islet tissue. Accumulations of lymphocytes and polymorphonuclear cells were scattered
throughout the gland. While necrosis of the pancreatic arterioles was not found, several
showed fibrous replacement of their media with periadventitial fibrosis.
No evidence of rheumatic carditis was present. Intercapillary glomerulosclerosis
was not found in the kidneys.
Death in this case can be attributed directly to shock from diabetic
acidosis. The diabetes either arose or became apparent during an illness
that first manifested itself in urticaria, shortly followed by a condition which
was interpreted by her physician as infectious in origin. This began almost
a year after the institution of treatment of hyperthyroidism with propyl-
thiouracil and 2 months after thiourea in large doses had been substituted.
That this was associated with acute arterial disease which persisted for the
better part of a month after the drug was omitted can be inferred from the
hypertension and fresh retinal lesions observed on June 14. Although the
nature of this illness suggests, and the character of the vascular lesions
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found at autopsy is compatible with, reaction to a drug, the final outburst
did not occur until 2 weeks after she resumed thiourea. Granted that this
was thiourea intoxication, the origin of all her major troubles appears to
have been an exacerbation of her hyperthyroidism by a respiratory infection
early in September of the preceding year.
C11918 (ES), female, born in 1894, was mentally deficient. Of her 4 children, 2
also proved to be defective. In 1929 she was admitted to an institution and in 1930
was sterilized. In 1937 bilateral pulmonary tuberculosis was discovered by x-ray. From
1940 to 1942 the lesions seemed to advance somewhat; but thereafter appeared to be
quiescent. At this time she was admitted to the Southbury Training School, where
attention was drawn to a goiter which was said to have been present since 1907.
In 1947 increased nervousness and hyperactivity were noted, together with tremor
of the hands and tachycardia. The basal metabolism proved to be +62 per cent. She
was given 15 drops of Lugol's solution and 75 mg. of thiourea daily. Her course is
illustrated in Chart 11. In February, 1948, and again in April, because the basal
metabolism remained elevated, the dosage was increased successively to 150 and then
to 200 mg. May 25 the basal metabolism was still +69 per cent and nervousness and
tachycardia persisted despite restricted activity and partial bed rest. There is some
doubt, however, whether the patient took her medicine regularly.
Because of her unreliability and failure to respond to therapy, she was sent to the
New Haven Hospital for thyroidectomy on June 2. On admission the temperature
was 98.80, pulse 146, respirations 26, blood pressure 110/70. She was thin, hyperactive
and silly, with excessively moist skin, bilateral enlargement of the thyroid, slight lid
lag, slight dulness over the apices of both lungs, and a slightly enlarged heart with
tic-tac sounds. The antithyroid therapy was continued unchanged. June 9 the tempera-
ture rose and June 13 urinary frequency was noted. Hemolytic streptococci were
recovered from the catheterized urine. It was discovered that the patient belonged to
that class of women who seem unaware of a full bladder when they are in the recum-
bent position. June 15 she was given penicillin which brought the temperature to
normal after 8 days.
June 26, because the SPI and pulse were still elevated and the weight was falling,
the dose of thiourea was increased to 280 mg. daily. July 4 the temperature again
began to rise. An infected tooth was extracted on July 9, but the temperature continued
to rise in spite of penicillin. July 11 a heavy growth of E. coli was recovered from
the urine. She was given full doses of sulfadiazine without apparent effect, but it was
discovered that she had been hiding the pills. She had meanwhile lost much weight,
her appetite had deteriorated to such an extent that she required parenteral fluids,
and intermittent glycosuria had appeared. Blood sugars, at first equivocal, later became
consistently elevated.
On July 27 her neck and upper anterior chest assumed a deep purplish-red hue,
which blanched on pressure, her pulse rose to 186 and her respirations to 55, without
orthopnea. A moderate secondary anemia had not been greatly affected by a trans-
fusion. The temperature persisted and E. coli continued in the urine. Probably because
of the high doses of thiourea the SPI had fallen to 6.5 -y per cent. Emaciation and
weakness increased continuously. July 30 she complained of photophobia, her neck
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the first of the two periods separated by the vertical double line, before the patient
entered the hospital, the time scale is contracted.
was stiff, reflexes absent, and a small hemorrhage was seen in the left retina. Profuse
rales were heard over the bases of both lungs, especially the left, and the liver seemed
to be enlarged. The catheterized urine was loaded with white blood cells and organisms.
Meanwhile streptomycin and digitalis had been begun. By August 2 her circulatory
state seemed improved; but 2 days later cyanosis and extreme tachycardia recurred.
More scattered retinal hemorrhages and blurring of the optic discs were found. The
spinal fluid was normal except for slightly increased pressure. Edema, which had
appeared somewhat earlier, increased. Urine cultures continued to defy therapy.
August 6, propylthiouracil, 400 mg. daily, was started because of the extreme
persistent tachycardia. By this time she was practically unable to move her lower
extremities, and her arms were so weak that she could not feed nor help herself, though
she took nourishing fluids when they were given to her. There was diffuse tenderness
in the lower extremities. On August 15, 11 days after propylthiouracil was begun,
her temperature, which had for a long time varied between 100.4 and 101.20, rose to
1030. From this time until her death, 8 days later, it ranged between 102.6 and
104.80 daily, although propylthiouracil was stopped on the 17th. Penicillin had been
given in doses of 600,000 units daily for a long time before this. With this terminal
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temperature, signs of pneumonia appeared in the left lower lobe, later spreading to
other parts of her lungs. In the latter part of her course, x-ray revealed enlargement
of the heart, a right pleural effusion, and pulmonary congestion. During the terminal
episode, because of her desperate condition, no x-rays were taken. On admission to
the hospital she had a leucocytosis of 13,800, toward the end this had risen to 28,400,
with 20 per cent non-segmented and 72 per cent segmented forms. She also had a
secondary anemia.
Anatomical findings at autopsy: Adenomatous goiter (165 grams); bilateral old
fibro-caseous and calcific pulmonary tuberculosis; confluent tuberculous pneumonia;
generalized arteriosclerosis; obliterative endarteritis of arteries of the kidneys and
periadrenal fat; scars of kidney cortex; infarct in left kidney; infarcts of spleen;
organizing thrombus in left ovarian and renal vein; atrophy of cerebral cortex;
symmetrical dilatation of cerebral ventricles.
The thyroid acini microscopically revealed involutional changes characteristic of
iodine effect. Groups of hyperplastic acini were interspersed among the involved
follicles.
The arterial lesions of the kidneys consisted of an old obliterative intimal and medial
process involving segments of the interlobular vessels. Identical changes were found
in the pericapsular arteries of the adrenals. Although scars were present in the renal
cortex the microscopic appearance of the kidneys was not that of ordinary pyelo-
nephritis. In some situations the vessel changes were present in relation to scarred
areas of cortex, but more often they were not. Furthermore the arterial lesions were
definitely out of proportion to the other changes present in the renal parenchyma. An
infarct was present in the left kidney, the renal vein of which was occluded by an
organizing thrombus. The splenic arterioles were the seat of hyalin arteriosclerosis.
No old or recent occlusions of these were demonstrated to account for the recent
infarcts. No acute arteriolar changes were present in any of the viscera.
There was moderate dilation and hypertrophy of the right ventricle. The liver
showed severe chronic passive congestion. There were no anatomical lesions of the
pancreas to suggest diabetes, nor were intercapillary changes present in the glomeruli
of the kidneys.
This patient has been included in the series because the clinical course of
her disease does not differ greatly from that of some of the other cases that
have been described. She can be distinguished from them only by the fact
that autopsy revealed reasons enough for symptoms and death without
implicating thio-drugs. Death may be attributed to her tuberculosis. The
arterial disease, though somewhat atypical, may be ascribed to the pyelo-
nephritis. Unexplained thrombophlebitis is so commonly encountered in
chronic diseases that no specific importance can be attached to it. She
illustrates resistance to the action of thiourea-or more precisely, perhaps,
exaggeration of hyperthyroidism-in the presence of infection. It was,
however, possible by large enough doses of, thio-drugs to bring the
hyperthyroidism under control.
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Discussion
Although this paper deals chiefly with the effects of thiourea, the
phenomena which it describes have been observed in varying degree after
all thio-drugs. Thiourea is given prominence in this particuar series only
because, for reasons stated above, it was, until recently, employed more
than any other member of its group.
The vomiting and febrile reactions occurring early in the course of
treatment with thio-drugs are unmistakably connected with these drugs.
These febrile reactions, like the occasional urticarial incidents, appear to be
allergic in nature. They are among the trivial allergic reactions that can
be elicited acutely by administration of the drug and are rapidly self-
terminative. It has been claimed, and in many instances demonstrated, that
they cease spontaneously after a short time if administration of the drug
which provoked them is continued. Since they are usually quite specific,
it is more advisable to substitute for the offending drug some other member
of the thio-group. Pathological leucopenia and agranulocytosis can also be
referred directly to the action of the drug, although it is more than possible
that other concomitant medications may have been responsible for some of
the cases that have been reported. In this respect thiourea has a peculiarly
innocent record.
It is far more difficult to establish a direct connection between the
thio-drugs and the late febrile disorders with which the body of this paper
is concerned. Even the autopsy findings in the 5 fatal cases are inconclusive.
Although these complications began while the patients were receiving
thiourea, definite association between the drug and fever or other symptoms
could not be demonstrated. Febrile responses and other symptoms were
clearly provoked by administration of thiourea in only 2 cases, A6280 and
B2143; and in the latter on other occasions temperature and skin lesions
appeared after the drug had been withdrawn and disappeared while it was
being given. It is this uncertainty which has compelled us to report all the
cases in detail.
One obstacle to the analysis of the problem is our relative ignorance of
the life history of patients with hyperthyroidism-what happens to them
with respect to other functions than that of the thyroid gland or beyond
that brief span or those recurrent episodes in which they interest the
surgeon or the endocrinologist. Selvaag' in a series of 392 patients with
hyperthyroidism found 9 with polyarthritis, 9 with humeroscapular arthritis,
and 2 with rheumatic fever, a proportion that compares well with that seen
in the present series of treated cases. It would be unjustifiable to exonerate
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thio-drugs on the basis of this evidence; but it serves to emphasize the need
for a broader study of hyperthyroidism and its associations.
It is necessary also to inquire whether the patients that have been
described belong to a particular class possessing pre-existing characteristics
that render them peculiarly susceptible to the types of reactions that have
been described. They are certainly not representative of the usual composi-
tion of a thyroid clinic. Of the 12 only 1, B2143, was under 30 years of age,
1 was under 50, 5 were more than 60 years old. Four had persistent out-
spoken hypertension; 4 others had high blood pressure at some time in the
course of their illnesses. Four had frank congestive heart failure when
treatment was begun and 3 others required digitalis at some time. Measure-
ment of SPI has facilitated the diagnosis of hyperthyroidism in patients
with heart failure. This and the fact that patients with circulatory complica-
tions are particularly likely to be referred for medical treatment has given
this clinic a somewhat unusual complexion. Nevertheless, it is a matter of
surprise that the younger population of the clinic has so generally escaped
these possibly toxic complications.
Of the 12 patients suspected of late febrile reactions, all but 2 had received
large doses of thiourea, 200 mg. or more, usually for long periods. With
the exceptions of C6107 and B7801, the duration of treatment varied from
10 to 22 months. These large doses were required in these cases to control
hyperthyroidism. In some instances attempts to reduce the quantities of
thiourea led to recrudescence of thyrotoxic symptoms; in some, such symp-
toms could be controlled by small doses. Others, because of some inter-
current condition, the nature of which was not always clear, developed
evidences of hyperthyroidism while on moderate doses that had been ade-
quate, necessitating the use of larger doses. These febrile complications,
therefore, appeared most frequently in subjects who were resistant to the
action of the drug. This resistance or variability in the response to therapy
is common to all thio-drugs. The doses required for the control of hyper-
thyroidism are not proportional to the severity of the clinical manifestations
nor to the degree of disturbance of the objective criteria of activity, basal
metabolism and SPI. In the course of treatment, moreover, on a constant
dose, evidences of activity vary widely in a certain proportion of cases. It
is conceivable that the febrile episodes in these cases are directly referable
not to the large doses of drug that were given, but to the factors that created
the resistance that made these large doses necessary.
In almost every instance these late febrile reactions were preceded or
accompanied by signs of increasing thyroid activity, not only in tachycardia,
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sweating, and nervousness, but also in rises of SPI, without change of the
dose of thiourea which had previously been effective. With subsidence of
symptoms, SPI sometimes (see, for example, B2143) fell in spite of a
reduction in the dose of the drug. Whether SPI could have been reduced
by larger doses of thiourea while the febrile complication persisted was not
tested in most cases out of concern lest the drug be the cause of the disorder.
In 2 of the fatal cases, B99489 and C11918, this course did result in reduc-
tion of SPI. In other cases interruption of therapy repeatedly led to rapid
exacerbation. The sequence of events suggested not that the patients had
become insensitive to the effects of the thio-drugs, but that the febrile
complication had aggravated the hyperthyroidism, thereby causing SPI
to rise.
This effect appears not to be peculiar to the particular type of febrile
complication under discussion. It occurred also in response to intercurrent
respiratory or urinary tract infections. The significance of the rises of SPI
in terms of thyroid activity was sometimes hard to evaluate. At their onset
they were not consistently paralleled by basal metabolism and resting pulse.
At their height, fever and other symptoms confused efforts at analysis.
Serum cholesterol usually proved to be within normal limits or low, never
high. In most instances the clinical pictures were indicative of hyper-
thyroidism. On the whole the fluctuations of SPI, though not quantitatively
proportional to other evidences of variation of thyroid activity, seemed
clinically plausible.
In a few instances, however, changes of SPI of an altogether different
order of magnitude were encountered. The most striking example is the
sudden rise to 71.5 y per cent in B2143. Figures of this magnitude have
not been observed with even the most severe hyperthyroidism. They ordi-
narily denote that the subject has recently received an injection of some
organic iodine compound, such as diodrast or priodax, that combines with
the serum proteins. A less extreme example of the same phenomenon was
observed in B54264 whose SPI rose to 46.0 y per cent. Apparently, in
a certain number of patients who have received thio-drugs for considerable
periods, high concentrations of SPI may occur that are not related to
thyroid activity. This anomaly does not appear to have any direct relation
to the febrile complications, although it has been seen most frequently in
patients with these complications. These points are well illustrated by Case
B88761, a woman of 72, who was first seen in October, 1946, with obvious
hyperthyroidism and heart failure, a basal metabolism of +27, and SPI 11.1
y per cent. On 15 drops of Lugol's solution and 210 mg. of thiourea,
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together with digitalis, she responded promptly, the symptoms disappearing
and SPI falling to 6.9 y per cent by November 6. At this time the dose of
thiourea was reduced to 70 mg. By February, 1947, the SPI had risen to
9.7 y per cent with some return of hyperthyroid symptoms. Two months
later, with frank hyperthyroidism, the SPI was 12.1 y per cent. The dose of
thiourea was, therefore, increased to 140 mg. daily. On this regime she
improved and seemed to maintain a euthyroid state throughout the spring
and summer. In October, however, she noticed rapid gain of weight, som-
nolence, and other signs of retardation. On October 29 she appeared hypo-
thyroid with SPI of 4.8 -y per cent. Thiourea was discontinued too long
and by December she was overactive again with SPI 10.1 y per cent. This
time she was given only 70 mg. of thiourea daily. Symptoms and signs
disappeared on this small dose. In May she was in excellent condition with
SPI 6.3 y per cent. She continued in this euthyroid state until October,
when again she noted increase of weight and retardation. This time, how-
ever, her voice also became deeper and she became mentally confused.
When seen October 27, she had all the symptoms and signs of myxedema,
together with heart failure. Her serum cholesterol, which had previously
been 233 mg. per cent, had risen to 394. Her SPI, however, was 10.8 y
per cent, a hyperthyroid value. The thiourea was discontinued and she was
given first 0.06 and later 0.03 gm. of thyroid daily. Improvement was
striking and immediate. November 1 cholesterol had fallen to 309 mg. per
cent, while SPI had risen to 20.8 y per cent. November 10, when she
seemed euthyroid, they were, respectively, 242 and 22.5. November 19 SPI
was 17.8 y per cent. November 24 thyroid was discontinued and January 7,
1949, she was given 100 mg. of propylthiouracil daily. March 18, 1949, she
was seen again, feeling well, cholesterol 299 mg. per cent, SPI 8.5 y per
cent. The impression was that the thyroid might be slightly hyperactive;
at least her appearance did not suggest myxedema. The significance of these
peculiarly high values of SPI is not clear. Obviously, when they occur,
SPI no longer can serve as a measure of thyroid activity. The most plausi-
ble explanation is that some abnormal compound is formed under the
influence of the thio-drug which behaves chemically like the circulating
thyroid hormone. The circumstances surrounding the appearance of the
phenomenon suggest that it is not altogether unrelated to thyroid activity.
The extremely high value of 71.5 y per cent in B2143 occurred during a
hyperthyroid phase. SPI fell during recovery, but in correspondingly gigan-
tic steps. The SPI of the myxedematous patient increased under the
influence of thyroid from 10 to 20 and 22 y per cent, an increment of 10
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to 12, instead of the usual 1 to 3 y per cent. The effect of this rise in terms
of signs and symptoms of thyroid activity, including fall of serum chol-
esterol, was no greater than that of the small rise that usually attends
correction of the hyperthyroid state. Whatever the cause or nature of these
spuriously high iodine values may be, they appear to be transitory. In the
subsequent course of B2143, with the establishment and maintenance of a
relatively steady euthyroid state, SPI fell to 6.0 y per cent. B88761, in
a state of euthyroidism or mild hyperthyroidism, at the last observation,
had a SPI of 8.5 y per cent, distinctly lower than the figure of 10.8 y per
cent found 4 months earlier, when she was obviously myxedematous. The
association of these specious values with the administration of thio-drugs
may be merely coincidental. SPI has been measured more frequently in
patients receiving thio-drugs than in any other group. In a large body of
data from normals and patients with a great variety of diseases, however,
no discrepancies of similar magnitude between SPI and other criteria of
thyroid activity have been encountered. They do not appear to have any
direct connection with toxic effects of thio-drugs or the febrile episodes
that have been described, since B88761 had no evidences of either.
As yet no explanation for the phenomenon can be offered. One can
speculate that the serum proteins may form some peculiarly stable com-
pound with iodine or with the thyroid hormone, or that the ability of the
tissues to utilize the hormone may be impaired. Neither explanation is
satisfactory. The problem is under investigation. It must not be inferred
that these misleading values occur frequently. The conviction remains that
SPI is the most reliable single criterion of thyroid activity. High values
that can be declared certainly spurious have been extremely rare, even
among patients who have received thio-drugs. Their low and capricious
incidence, indeed, will be the greatest obstacle to their elucidation.
Some other points about the reactions of these patients with febrile
complications may be worth mentioning. A significant proportion during
these episodes have had some evidences of impairment of liver function.
This was especially prominent in B90726. Several of the others had slightly
positive cholesterol flocculation tests and increases of cholesterol ratios
(free: total cholesterol) to 0.33 and 0.35 instead of the normal 0.24 to 0.32.
In addition, fatty acids of neutral fat exceeded 6 mM. per liter in many
instances. Such disturbances of lipid patterns do not occur in uncomplicated
thyroid disease; they usually betoken an accompanying hepatic disorder.
Disturbances of carbohydrate metabolism, in one instance amounting to the
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development of true diabetes, were notably frequent, but can not be
considered statistically significant.
In spite of the time spent in description and discussion of these cases, a
satisfactory assessment of the responsibility of thiourea is impossible, even
in the 5 fatal cases. Two of the latter did have vascular lesions and one had
skin lesions of types that there is reason to believe may be produced by
drugs and other substances that can provoke allergic phenomena. Marine
and Baumann'8 reported the occurrence of periarteritis nodosa in 2 rats
after administration of thiourea. As they pointed out, however, the incidence
was no higher than that of spontaneous periarteritis nodosa in other re-
ported series of rats. Most of the other patients had symptoms and signs
suggestive of kindred disorders. The constitution of the group, however,
was peculiar and the incidence among them of such disorders, had they not
received thiourea, is unpredictable. While responsibility can not be fixed
unreservedly upon thiourea, the drug must be held suspect of complicity
in a certain proportion of the cases. They have been presented in extenso
in the hope that more attention will be given to the incidence in hyper-
thyroidism of such conditions and their relation to treatment with thio-
drugs. If all these disorders are laid at the door of thiourea or thio-drugs,
medical treatment of hyperthyroidism is not thereby discredited. The only
conclusions to be drawn from this study to date might be that elderly or
aged patients with evidences of vascular disease and with hyperthyroidism
that can not be controlled over long periods by large doses of thio-drugs,
may develop serious febrile illnesses associated with arthritis and peculiar
lesions of the skin that may indicate or compel alteration or interruption of
the treatment. They may, therefore, be regarded as unfavorable subjects for
this type of therapy. Since the same patients make up the worst operative
risks, the physician is left with Hobson's choice.
Conclusions
Of approximately 300 patients who have been treated for hyperthyroidism
with thiourea, 35 while under therapy developed signs or symptoms of some
kind that aroused suspicions of intoxication from the drug. The drug could
be clearly incriminated in 6 cases, as clearly exonerated in 17. Neither
agranulocytosis nor pathological leucopenia occurred in the series. One
patient developed urticaria definitely referable to the drug after continuous
treatment with small doses for 22 months. Three patients had febrile re-
actions within the first 2 weeks. In 2 the drug was discontinued because it
provoked nausea. The main body of the paper is devoted to the discussion
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of the significance of febrile reactions with various joint and skin manifesta-
tions that complicated the course of the remaining 12 patients. Five of
these died and came to autopsy.
In a few instances the SPI of patients who had been treated for long
periods with thio-drugs rose to concentrations that were quite out of
keeping with the state of thyroid activity.
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